Arguseye
Founded 2017 · 25 employees on LinkedIn · 2 known investors
ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing. Its patented Auga platform combines sensor hardware, sensor chips, and software to track critical quality attributes and process parameters, including in-line detection of antibody aggregates and fragments during purification.
Investors · 2
Frequently asked questions
- What does Arguseye do?
- ArgusEye develops LSPR-based biosensor systems for real-time monitoring and analytics of bioprocesses in biopharmaceutical development and manufacturing. Its patented Auga platform combines sensor hardware, sensor chips, and software to track critical quality attributes and process parameters, including in-line detection of antibody aggregates and fragments during purification.
- Who are Arguseye's investors?
- Arguseye's investors include EIR Ventures, Voima Ventures.